BELLUS Health Inc
TSX:BLU
BELLUS Health Inc
TSX:BLU
Price:
19.48 CAD
-0.1%
Market Closed
Updated:
May 2, 2024
BELLUS Health Inc
Cash from Financing Activities
|
BELLUS Health Inc
Cash from Financing Activities Peer Comparison
Comparables:
ZYME
RPTX
FUSN
AUPH
EDT
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
BELLUS Health Inc
TSX:BLU
|
Cash from Financing Activities
$163.8m
|
CAGR 3-Years
31%
|
CAGR 5-Years
62%
|
CAGR 10-Years
35%
|
|
|
Zymeworks Inc
NYSE:ZYME
|
Cash from Financing Activities
$81.8m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Cash from Financing Activities
$842k
|
CAGR 3-Years
-85%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Cash from Financing Activities
$142m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Cash from Financing Activities
-$5.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Spectral Medical Inc
TSX:EDT
|
Cash from Financing Activities
CA$5.4m
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
See Also
What is BELLUS Health Inc's Cash from Financing Activities?
Cash from Financing Activities
163.8m
USD
163.8m
USD
Based on the financial report for Mar 31, 2023, BELLUS Health Inc's Cash from Financing Activities amounts to 163.8m USD.
What is BELLUS Health Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
35%
35%
Over the last year, the Cash from Financing Activities growth was -22%. The average annual Cash from Financing Activities growth rates for BELLUS Health Inc have been 31% over the past three years , 62% over the past five years , and 35% over the past ten years .
You don't have any saved screeners yet
